The following patent should be studied. .....
Patent number: 10265372 "Molecular composition for enhancing and rejuvenating maintenance and repair of mammalian tissues" - rejuvenation of tissues by oxytocin together with an ALK5 antagonist.
Here is the patent
https://patents.just...patent/10265372
The amount of the OXTR agonist for the contacting step, e.g., for administering to a subject may be in the range of 7.5 nM-30 nM and the amount of the ALK5 antagonist may be in the range of 0.05 μM-3 μM. The ratio of OXTR agonist to the ALK5 antagonist used for contacting step, e.g., for administering to a subject as disclosed herein may be 1:50, 50:1, 1:40, 40:1, 1:30, 30:1, 1:25, 25:1, 1:10, 10:1, 1:5, 5:1, or 1:1.
Now, as with most most patent papers, the above link is a jumbled mess and offers little in the way of actionable information.
If we are unable to inject as much Oxytocin as would be required for this exact experiment, how about maximizing the circulating dose of Oxytocin through Trenbolone and Estrogen (or Estradiol) injections:
:text=oxytocin%20in%20cattle-,Chronic%20exposure%20to%20anabolic%20steroids%20induces%20the%20muscle%20expression%20of,Physiol%20Genomics' class='bbc_url' title='External link' rel='nofollow external'>https://pubmed.ncbi....hysiol Genomics.
Chronic exposure to anabolic steroids induces the muscle expression of oxytocin and a more than fiftyfold increase in circulating oxytocin in cattle
"...We also observed an ∼50-fold higher level of circulating oxytocin in the plasma of treated animals at the time of biopsy. "
A mere 20 days of exposure to Trenbolone and Estrogen resulted in the above results and for a human they are totally doable. Bodybuilding enthusiasts do much, much longer cycles of Trenbolone.
-------------------------------------------------------
The other issue that remains to be resolved is whether the ALK5i dose is tolerable. As far as I know, a number of human studies with ALK5i have been done and we do have some idea about how much can be used without severe side effects. If the ALK5i dose mentioned above is doable, enhancing Oxytocin through those anabolic hormones remains the most viable route -at least, as far as I can see.